8-K
filed November 3, 2023, 7:59 PM ET
ticker VIVS
CIK 0001497253
other
confidence high
sentiment neutral
materiality 0.35
Organovo shareholders approve 2023 ESPP but reject officer exculpation amendment
VivoSim Labs, INC.
- 2023 ESPP approved with 91.11% of votes cast; reserves 45,000 shares; effective October 31, 2023.
- Amendment to certificate of incorporation (officer exculpation) failed: 794,723 for, 63,936 against; needed majority of 8,718,203 outstanding shares.
- Directors Keith Murphy (786,897 for) and Adam Stern (812,172 for) elected as Class III directors until 2026.
- Ratification of auditor Rosenberg Rich Baker Berman P.A. approved by 91.83% of votes cast.
- Advisory vote on named-executive compensation approved by 85.78% of votes cast.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VivoSim Labs, INC. shareholders rejected Amendment to Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation at the 2023-10-31 meeting.
- Proposal
- charter amendment
- Outcome
- failed
- Meeting
- 2023-10-31
Exact text from the filing
The Company held the Annual Meeting on October 31, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VivoSim Labs, INC. shareholders approved Election of Keith Murphy and Adam Stern as Class III directors at the 2023-10-31 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-10-31
Exact text from the filing
The Company held the Annual Meeting on October 31, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VivoSim Labs, INC. shareholders approved Advisory vote on compensation of named executive officers at the 2023-10-31 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-10-31
Exact text from the filing
The Company held the Annual Meeting on October 31, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VivoSim Labs, INC. shareholders approved Approval of 2023 ESPP at the 2023-10-31 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-10-31
Exact text from the filing
The Company held the Annual Meeting on October 31, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VivoSim Labs, INC. shareholders approved Ratification of appointment of Rosenberg Rich Baker Berman P.A. as independent registered public accounting firm for fiscal year ending March 31, 2024 at the 2023-10-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-10-31
Exact text from the filing
The Company held the Annual Meeting on October 31, 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.